Bibliographic Info
GuidelineConsolidated guidelines on HIV prevention, testing, treatment, service delivery and monitoring: recommendations for a public health approach
Year of Publication2021
Issuing InstitutionWHO
Recommendation
Status
Maintained
Recommended in favor
Strong
Certainty of evidence
Low
Children. When available, atazanavir/r (ATV/r), darunavir/r (DRV/r), lopinavir/r and RAL may be considered as alternative third drug options for post-exposure prophylaxis
Also Featured In
This recommendation also appears in the following guidelines:
Originally Developed
Guideline
Updated recommendations on first-line and second-line antiretroviral regimens and post-exposure prophylaxis and recommendations on early infant diagnosis of HIV
Year2018
InstitutionWHO
Guideline
Guidelines for HIV post-exposure prophylaxis
Year2025
InstitutionWorld Health Organization